Clinical Trials Research Groups

Cardiology Research

Surrey Memorial Hospital Cardiology Clinical Trials Inc. conducts both inpatient and outpatient clinical trials in the areas of:

  • Acute Coronary Syndromes (hospitalization with heart attack/angina)
  • Congestive Heart Failure (acute in hospital as well as outpatient studies)
  • Lipid lowering treatments (patients with high cholesterol)
  • Cardiovascular disease and Diabetes combined

Most of these studies are for promising new drug treatments aimed at preventing heart attacks and strokes. We are also participating in a registry and a quality of life initiative for acute coronary syndrome.

The research group consists of 8 Cardiologists, 4 coordinators (2 Full time/ 2 part time) and an Administrative Assistant. On average there are 15 studies ongoing at various stages at any given time. For further information, contact

Critical Care

Critical Care research in Fraser Health is conducted at Royal Columbian Hospital (RCH) under the direction of Dr. Steven Reynolds, Head and Research Director, Department of Critical Care. The research program’s primary focus is to conduct publicly funded trials, largely in collaboration with the highly successful Canadian Critical Care Trials Group, in addition to industry funded studies and investigator driven studies. Our site staff has a wide range of experience working with various pharmaceutical corporations and contract research organizations.

The Critical Care team at RCH provides care to patients with complex medical conditions requiring advanced respiratory support, hemodynamic monitoring and support, cardiac monitoring and other life supporting treatment. Our multidisciplinary team consisting of Intensivists, Pharmacists, Registered Respiratory Therapists, and Registered Nurses with advanced training in critical care, work collaboratively to provide exceptional care. Our physicians are in charge of a total of 30 critical care beds which provide care for over 2,000 patients a year.

For more information please contact the Critical Care Clinical Research Coordinator at 604-520-4695.

Multiple Sclerosis Clinical Research Studies

The Fraser Health Multiple Sclerosis clinic opened in November 2004 to provide a comprehensive, community based clinic to the region.  Prior to that time, Fraser Health was the only region in British Columbia without an MS clinic for its 3000 patients.  The clinic has a comprehensive, multidisciplinary team (Neurologists, Neuro-ophthamologists, a Physical medicine and Rehabilitation physician, an Internal Medicine physician, MS certified nurses).  The clinic was accredited in May 2005 as a full member of the Consortium of Multiple Sclerosis Centers, a North American multi-disciplinary organization providing networking for all health care professionals specializing in the care of Multiple Sclerosis patients, after demonstrating excellence in the clinical care, education, and research related to MS, specifically related to the investigation of problems posed by Multiple Sclerosis.

The clinic is also home to a clinical trials department for Multiple Sclerosis under the direction of Principal Investigator, Dr. Galina Vorobeychik.   With 40 trials in the past 10 years, we aim to provide patients with research opportunities and early access to potential new treatments and therapies for: Relapsing Remitting, Secondary Progressive and Primary Progressive sub-types of MS.


The Burnaby Hospital Regional Cancer Centre has been conducting medical research since 2002 under the direction of Oncologist/Hematologist Dr. Wendy Lam. The majority of the research conducted at the BHRCC is Phase II & III drug trials targeted at various cancers, blood disorders and improving supportive care.

For more information on the types of studies that are ongoing, please contact Sue Baynham, RTT, Clinical Research Coordinator, BC Community Oncology Trialists at 778 846-2011 or via email at


Orthopaedic Research at Royal Columbian Hospital is alive and well. Our research staff and surgeons are actively enrolling in 8 Prospective Randomized Studies and carrying out follow-up on 5 additional studies that have closed enrolment. These are based on trauma and elective studies, covering a wide range of pathologies. Most of the research is funded by working as co-invesitgators on grant applications with academic investigators who obtain grants from CIHR, NIH, Orthopaedic Trauma Association and the Canadian Arthritis Society or by industry.

For further information regarding any of the above, please contact Mauri Zomar, Research Coordinator, Orthopaedic Research Office at (604) 520-4855.

Ridge Meadows Hospital

Ridge Meadows Hospital has been actively participating in clinical research for 20 years. Beginning with the GUSTO trial early in the thromolytic era to the present research involving thrombin receptor antagonists and novel heart failure therapies, cardiac research has been the main focus at our site. Other research topics have included antibiotics in pneumonia, asthma and COPD. The internal medicine research team includes Drs. Ervin, Auersperg and Tsui. Our coordinators include Sandi Thiessen and Marlene Ouellette. For further information, contact Dr. Ervin at 604-466-8199 or by email at

Fraser Clinical Trials

Fraser Clinical Trials is a clinical research center that is dedicated to improve the health and quality of our patients through new and innovated therapies.

The Fraser Clinical team works with Investigators in multi-therapeutic areas serving New Westminster, Surrey and the Fraser Valley of British Columbia. For almost three decades, we have been helping physicians integrate research with their private practices. Fraser Clinical Trials is committed to supporting Physicians so they may offer innovated therapies to their patients. Fraser Clinical Trials delivers high quality data, maintains regulatory compliance, and supports all administrative aspects of the trial.